Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?

doi:10.3748/wjg.v24.i17.1825

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8455)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

693

HTML

4806

Figures (1-1)

361

Tables (1-2)

352

Sum=6212

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1077

Download

1166

Sum=2243

May 7, 2018 (publication date) through Feb 8, 2025

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. May 7, 2018; 24(17): 1825-1838
Published online May 7, 2018. doi: 10.3748/wjg.v24.i17.1825

Full Size Figure Download Figure

$[Label] $[Caption_0] $[Caption_1]

Citation: Moreno-Cubero E, Arco RTSD, Peña-Asensio J, Villalobos ES, Míquel J, Larrubia JR. Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients? World J Gastroenterol 2018; 24(17): 1825-1838
URL: https://www.wjgnet.com/1007-9327/full/v24/i17/1825.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i17.1825